NDAQ:TNXP - Post Discussion
Post by
whytestocks on Jun 18, 2024 3:45pm
Tonix Pharmaceuticals Presented Data Comparing Real-World Tr
BREAKING NEWS: $TNXP Tonix Pharmaceuticals Presented Data Comparing Real-World Treatment of Migraine with Industry Guidelines for Non-Oral Products at the Annual Scientific Meeting of the American Headache Society (AHS) | BenzingaGap in non-oral prescriptions relative to AHS guidelines represents an opportunity to increase awareness of Tonix's two FDA-approved non-oral...
TNXP - Tonix Pharmaceuticals Presented Data Comparing Real-World Treatment of Migraine with Industry Guidelines for Non-Oral Products at the Annual Scientific Meeting of the American Headache Society (AHS) | Benzinga
Be the first to comment on this post